FIELD: medicine.
SUBSTANCE: hyaluronidase immobilised on polyethylene glycol is introduced into laboratory animals intranasally in a dose of 16 units. Hyaluronidase is introduced once a day on 1st, 3rd, 7th and 10th day after administering bleomycin that is a pulmonary fibrosis simulation factor.
EFFECT: higher pulmonary tissue resistance to fibrotic depositions, including prevents a reverse process of fibrosis formation ensured by the properties of pegylated hyaluronidase and developed mode of its administration that leads to a prolonged antifibrotic effect with low toxicity and immunogenicity of the effects on the body.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR IMPROVING THERAPEUTIC EFFECTIVENESS IN LUNG TISSUE DISORDERS AFTER ACTION OF CYTOSTATICS | 2012 |
|
RU2497523C1 |
MEANS FOR PNEUMOFIBROSIS PREVENTION AND TREATMENT AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2646810C1 |
DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
AGENT POSSESSING ANTI-INFLAMMATORY AND ANTIFIBROTIC ACTION IN PULMONARY TISSUE, AND CYTOSTATIC ACTION | 2012 |
|
RU2479312C1 |
AGENT POSSESSING ANTI-INFLAMMATORY AND ANTIFIBROTIC ACTION IN PULMONARY TISSUE, AND CYTOSTATIC ACTION | 2013 |
|
RU2530651C1 |
AGENT PREVENTING DEVELOPING DISORDERS IN PULMONARY TISSUE AND BLOOD SYSTEM ACCOMPANYING CYTOSTATIC ACTION | 2011 |
|
RU2464983C1 |
PREPARATION PREVENTING DEVELOPMENT OF ABNORMALITIES IN LUNG TISSUE UNDER CYTOSTATIC IMPACT | 2011 |
|
RU2455991C1 |
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
Authors
Dates
2013-09-27—Published
2012-04-04—Filed